Form 8-K - Current report:
SEC Accession No. 0000950170-25-008994
Filing Date
2025-01-27
Accepted
2025-01-27 07:07:10
Documents
25
Period of Report
2025-01-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20250127.htm   iXBRL 8-K 45423
2 EX-99.1 allk-ex99_1.htm EX-99.1 12499
3 GRAPHIC allk-ex99_1s1.jpg GRAPHIC 216180
4 GRAPHIC allk-ex99_1s2.jpg GRAPHIC 873454
5 GRAPHIC allk-ex99_1s3.jpg GRAPHIC 179920
6 GRAPHIC allk-ex99_1s4.jpg GRAPHIC 170773
7 GRAPHIC allk-ex99_1s5.jpg GRAPHIC 346704
8 GRAPHIC allk-ex99_1s6.jpg GRAPHIC 323782
9 GRAPHIC allk-ex99_1s7.jpg GRAPHIC 227861
10 GRAPHIC allk-ex99_1s8.jpg GRAPHIC 212549
11 GRAPHIC allk-ex99_1s9.jpg GRAPHIC 143098
12 GRAPHIC allk-ex99_1s10.jpg GRAPHIC 277548
13 GRAPHIC allk-ex99_1s11.jpg GRAPHIC 345865
14 GRAPHIC allk-ex99_1s12.jpg GRAPHIC 136004
15 GRAPHIC allk-ex99_1s13.jpg GRAPHIC 176885
  Complete submission text file 0000950170-25-008994.txt   5172288

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20250127.xsd EX-101.SCH 23883
28 EXTRACTED XBRL INSTANCE DOCUMENT allk-20250127_htm.xml XML 4513
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 25555754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)